老虎證券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Motif Bio plc
0.1050
0.0000
成交量:
- -
成交額:
- -
市值:
5,096.69萬
市盈率:
-2.17
高:
0.1050
開:
0.1050
低:
0.1050
收:
0.1050
52周最高:
11.50
52周最低:
0.0750
股本:
4.85億
流通股本:
4.83億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.0483
每股收益(LYR):
-0.0492
淨資產收益率:
170.83%
總資產收益率:
-53.86%
市淨率:
-5.71
市盈率(LYR):
-2.14
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Motif Bio plc
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.motifbio.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Motif Bio plc在英格蘭和威爾士註冊成立於2014年11月20日,為了在AIM首次公開發行的目的,並成為在特拉華州註冊成立於2003年12月2日的Motif BioSciences公司的控股公司,在歷史上通過它們開展業務。他們是一家臨床階段的生物製藥公司,從事旨在對抗引起多重耐藥細菌住院患者嚴重和危及生命的感染有效的新抗生素的研發。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MTFB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MTFB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","market":"US","secType":"STK","nameCN":"Motif Bio plc","latestPrice":0.105011,"timestamp":1577826000000,"preClose":0.105011,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":482768055,"shares":485348166,"eps":-0.048292,"marketStatus":"退市","change":0,"latestTime":"12-31 16:00:00 EST","open":0.105011,"high":0.105011,"low":0.105011,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.048292,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773734400000},"marketStatusCode":5,"adr":1,"adrRate":20,"listingDate":1479445200000,"exchange":"NASDAQ","adjPreClose":0.105011,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","floatShares":482768055,"roa":"-53.86%","roe":"170.83%","lyrEps":-0.049151,"shares":485348166,"dividePrice":0,"high":0.105011,"amplitude":0,"preClose":0.105011,"low":0.105011,"week52Low":0.075,"pbRate":"-5.71","week52High":11.4999,"institutionHeld":0,"latestPrice":0.105011,"eps":-0.048292,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.048292,"open":0.105011},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTFB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTFB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.motifbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Motif Bio plc在英格蘭和威爾士註冊成立於2014年11月20日,為了在AIM首次公開發行的目的,並成為在特拉華州註冊成立於2003年12月2日的Motif BioSciences公司的控股公司,在歷史上通過它們開展業務。他們是一家臨床階段的生物製藥公司,從事旨在對抗引起多重耐藥細菌住院患者嚴重和危及生命的感染有效的新抗生素的研發。","exchange":"NASDAQ","name":"Motif Bio plc","nameEN":"Motif Bio plc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":null}}